You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-KAL1 antibody (ab55266)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-KAL1 antibody
See all KAL1 products (3) ...

Description

Mouse monoclonal to KAL1

Tested applications

WBmore details

Cross reactivity

Reacts with

Recombinant Fragment

Predicted to work with

Human

Immunogen

Recombinant fragment, corresponding to amino acids 548-658 of Human KAL1

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein G purified

Clonality

Monoclonal

Isotype

IgG2a

Light chain type

kappa

  • Western blot - KAL1 antibody (ab55266)Western blot - KAL1 antibody (ab55266) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab55266 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: Use at a concentration of 1-5 µg/ml.

This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

May be an adhesion-like molecule with anti-protease activity.

Involvement in disease

Defects in KAL1 are the cause of Kallmann syndrome type 1 (KAL1) [MIM:308700]; also known as hypogonadotropic hypogonadism and anosmia. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In some patients other developmental anomalies can be present, which include renal agenesis, cleft lip and/or palate, selective tooth agenesis, and bimanual synkinesis. In some cases anosmia may be absent or inconspicuous.

Sequence similarities

Contains 4 fibronectin type-III domains.
Contains 1 WAP domain.

Post-translational
modifications

N-glycosylated.

Cellular localization

Cell surface.

Target information above from: UniProt accessionP23352 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • KAL antibody
  • Adhesion molecule-like X-linked antibody
  • ADMLX antibody
  • Anosmin-1 antibody
  • HHA antibody
  • KAL1 antibody
  • KALIG 1 antibody
  • KALIG1 antibody
  • Kallmann syndrome 1 sequence (anosmin 1) antibody
  • Kallmann syndrome 1 sequence antibody
  • Kallmann syndrome interval gene 1 antibody
  • Kallmann syndrome protein antibody
  • KALM antibody
  • KALM_HUMAN antibody
  • KMS antibody
  • OTTHUMP00000022873 antibody
see all

Anti-KAL1 antibody images:

  Western blot - KAL1 antibody (ab55266)

Western blot - KAL1 antibody (ab55266)

Western blot against tagged recombinant protein immunogen using ab55266 KAL1 antibody at 1ug/ml. Predicted band size of immunogen is 38 kDa.

This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

References for Anti-KAL1 antibody (ab55266)

ab55266 has not yet been referenced specifically in any publications.

Publishing research using ab55266? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"